Dr. Teddy Yang appointed to Vice President and Head of Biologics Discovery at Shanghai ChemPartner
Shanghai, China(Mar 28, 2019) – Shanghai ChemPartner today announced the appointment of Teddy Yang, Ph.D. as the Vice President and Head of Biologics Discovery at the company headquarters in Shanghai, China. Dr. Yang has more than 20 years of experience in the pharmaceutical industry. He has previou...ChemPartner Will Participate in BIO-Europe Spring in Vienna, Austria in March 2019
Shanghai, China (March X, 2019) – March 25-27, 2019, ChemPartner will attend the 13th Annual International Partnering Conference BIO-Europe Spring in Vienna, Austria. With nearly 1,500 companies from 55 countries around the world, BIO-Europe is set to be a premier venue to engage with global life sc...
ChemPartner will be at the Boulder Peptide Symposium 2018
ChemPartner, a leader in Peptide Synthesis and Development, will be at the Boulder Peptide Symposium, Sept. 24-27, 2018 in Boulder, Colorado. The program was organized by Dr. Yvonne Angell, who is the Head of Peptide Operations at ChemPartner. There are 43 speakers, including a Showcase of emerging ...
Shanghai ChemPartner Announces Merger Deal Closure with Quantum
SHANGHAI, Aug. 16, 2018 /PRNewswire/ -- Shanghai ChemPartner, a leading life science organization providing high-quality and cost-effective drug discovery and development services, announced the closure of the merger deal with Quantum Hi-Tech China Biological. Quantum, in a press release in 2017, ...Berkeley Lights and ChemPartner Collaborate on Accelerating Antibody Discovery
EMERYVILLE, Calif., June 27, 2018 /PRNewswire/ — Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today that it has entered into a collaboration with ChemPartner Co., Ltd. (ChemPartner) focused on accelerating ChemPartner’s monoclonal antibody (mAb) discovery workflow utilizi...Dr. Ming Liu joins ChemPartner as Vice President and Head of Biology and Pharmacology
Shanghai, China (June 12, 2018) – Shanghai ChemPartner today announced the appointment of Ming Liu, Ph.D. as Vice President and the Head of Biology and Pharmacology at the company headquarters in Shanghai, China. Dr. Liu has more than 25 years of experience in drug discovery and development, with a ...
The 2017 Best Life Science Contract Research Organization (CRO), ChemPartner, Chooses CAS SciFinder® to Enable Closer Collaboration with Customers
Columbus, Ohio (April 16, 2018) – CAS, a division of the American Chemical Society (ACS), announced today a multi-year agreement to provide SciFinder to all scientists at ChemPartner, an R&D service provider for the pharmaceutical and biotech industry. ChemPartner was named Best Life Science CRO...Shanghai ChemPartner Sponsors Peptide Therapeutic Foundation(PTF)
Shanghai, China (October 25, 2017) – Shanghai ChemPartner today announced their sponsorship of the Peptide Therapeutics Foundation (PTF), a not-for-profit organization established to promote the research and development of peptide therapeutics. ChemPartner, a leading research organization, is a true...